Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. VTRS
VTRS logo

VTRS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Viatris Inc (VTRS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
17.170
1 Day change
-1.27%
52 Week Range
17.530
Analysis Updated At
2026/04/24
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Viatris Inc (VTRS) is not a strong buy for a beginner, long-term investor at this moment. While the stock shows some positive technical indicators and analyst upgrades, the financial performance is weak, hedge funds are selling, and the stock trend suggests potential downside in the short term. Given the user's preference for long-term growth and the lack of immediate strong catalysts, holding off on investment is recommended for now.

Technical Analysis

The technical indicators show a mixed picture. The MACD is positive and contracting, suggesting bullish momentum. The RSI is neutral at 70.269, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its resistance level (R1: 14.988), which could act as a barrier. However, the stock trend analysis indicates an 80% chance of a short-term decline (-0.7% in the next day, -1.84% in the next week, -4.47% in the next month).

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

The low put-call ratios indicate a bullish sentiment among options traders. However, the implied volatility (IV) is relatively high at 39.88, suggesting potential price swings.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
9

Positive Catalysts

  • and positive commentary on revenue upside, cost savings, and pipeline growth. Bullish technical indicators such as MACD and moving averages.

Neutral/Negative Catalysts

  • Hedge funds are selling heavily (247.32% increase in selling last quarter). Financial performance in Q4 2025 shows declining net income (-34.15% YoY) and EPS (-30.23% YoY). Stock trend analysis predicts short-term downside.

Financial Performance

In Q4 2025, revenue increased by 4.97% YoY to $3.7 billion, and gross margin improved to 40.25% (+1.80% YoY). However, net income dropped significantly (-34.15% YoY) to -$340.1 million, and EPS fell to -0.3 (-30.23% YoY), indicating weak profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have generally positive views, with multiple upgrades and increased price targets (e.g., UBS to $20, Barclays to $17). However, some analysts maintain a Neutral rating, citing concerns about lower EBITDA growth and muted market reactions.

Wall Street analysts forecast VTRS stock price to fall
4 Analyst Rating
Wall Street analysts forecast VTRS stock price to fall
2 Buy
1 Hold
1 Sell
Hold
Current: 17.170
sliders
Low
10
Averages
13.25
High
16
Current: 17.170
sliders
Low
10
Averages
13.25
High
16
Truist
Buy
maintain
$18 -> $20
AI Analysis
2026-05-08
New
Reason
Truist
Price Target
$18 -> $20
AI Analysis
2026-05-08
New
maintain
Buy
Reason
Truist raised the firm's price target on Viatris to $20 from $18 and keeps a Buy rating on the shares. The company's Q1 results featuring a 5% revenue beat and 10% operational EBITDA growth represent a clear pivot point for investors who have sidelined the name while awaiting proof of consistent execution, the analyst tells investors in a research note.
JPMorgan
Neutral
maintain
$17 -> $18
2026-05-08
New
Reason
JPMorgan
Price Target
$17 -> $18
2026-05-08
New
maintain
Neutral
Reason
JPMorgan raised the firm's price target on Viatris to $18 from $17 and keeps a Neutral rating on the shares.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for VTRS
Unlock Now

People Also Watch